Sentiment Analysis of the earnings transcript to help figure out if there are any bullish or bearish sentiments that could be gathered from it. We're doing ML and AI based analysis on the earnings call to get some more insights.
Please consider a small donation if you think this website provides you with relevant information
| Statement |
|---|
| And in particular in the jumbo end of the market which is where we focus and where we have distinct competitive advantages |
| And sales were also up 16% on a constant currency basis driven by strong growth in Mexico and Chile and solid persistency across the region |
| As you can see from the report we posted last night, MetLife delivered another quarter of strong underlying results with sustained business momentum |
| So as long as that continues, we think we've got a really solid platform on which to leverage the higher sales |
| And concentrating on those elements within our control, such as balance sheet security, investment performance, reserve adequacy, responsible growth, expense efficiency and capital deployment to name just a few, we have positioned MetLife to generate significant value for our shareholders and other stakeholders for many years to come |
| And so the stronger interest rates have really helped us |
| Overall, we've had a very strong quarter and year-over-year sales continue to be very strong |
| So we're excited for the opportunities that are out there |
| Our investment portfolio has stayed up in quality and continues to perform well |
| Adjusted earnings excluding notable items totaled $483 million an all-time high and up 16% from a year ago |
| Underwriting results in the quarter for both Group Life and Non-Medical Health were outstanding |
| Year-to-date sales are up 11% while adjusted PFOs are up more than 4% in the quarter reflecting the impact of our contracts and within our 4% to 6% outlook range which we expect to achieve for the full year |
| So all these factors combined with our disciplined underwriting pricing as well as efficiency focus are contributing to the solid earnings performance and sustained momentum |
| And a good example is what you referred to that Michel mentioned and is opening around the launch of our new integrated platform, which provides embedded insurance capabilities for our distribution partners and thus creating a differentiating competitive advantage for us across the region |
| And on the top-line side, the positive trajectory continues as you mentioned with solid double-digit growth consistent with our expectations |
| So we're overall very pleased with our results for the quarter |
| Looking to Retirement and Income Solutions or RIS adjusted earnings excluding notable items totaled $409 million up 60% from the prior year driven by higher recurring interest margins, better variable investment income and higher asset bases |
| Sales in the quarter were very strong across a range of products including pension risk transfer with roughly $1.5 billion booked as well as structured settlements and UK longevity reinsurance |
| We continue to see good growth there |
| Our focus so far has been on the immediate with RV only part of the market and we see significant pipeline there and we're able to win business at healthy IRRs |
| Following record PRT sales in 2022, market activity is expected to remain strong for the foreseeable future |
| These findings confirm what I have said before we should continue to see a strong pipeline for our pension risk transfer business |
| Adjusted earnings excluding notable items of $369 million were 23% above a year ago on better variable investment income |
| And we see a very healthy pipeline ahead and really with a lot of visibility into 2024 |
| Further Latin America posted healthy 16% gains in both sales and adjusted PFOs on a constant currency basis |
| So we're pretty pleased with our performance this quarter |
| Those are differentiating capabilities that we have and distinct competitive advantages that we will maintain and continue to invest in |
| And we believe over time, will allow us to fuel further growth and maintain very robust margins here |
| The favorability we're seeing in disability is coming from solid underwriting return to health capabilities deployment of data technology, predictive analytics in how we're running this business in particular investments we're also making in the live and absent space |
| Some of this favorability is stemming from a favorable macro environment |
| Statement |
|---|
| As we previously indicated Variable investment income of $179 million fell below our quarterly outlook expectation |
| The third quarter result reflects the negative impact of certain required accounting adjustments associated with our previously announced reinsurance transaction |
| And finally, 85% of plan sponsors expressed concern over missing an attractive window to secure an annuity buyout at competitive rates |
| Also, we had net investment losses from our normal trading activity in the portfolio, given the rising interest rate environment |
| Total US statutory adjusted capital has absorbed a negative impact of roughly $300 million associated with the investments expected to be transferred to Global Atlantic, which will be recovered upon closing |
| In Asia, the net unfavorable impact was due to lapse rate changes across life and accident & health products in Japan, as well as lowering lapse rates and expected fund returns for variable life products in Korea |
| If I think for us specifically on a go-forward basis, you should think about the mortality ratio which is below the guidance for this quarter |
| In addition, we had net derivative losses due to higher interest rates and strengthening of the US dollar versus multiple currencies, primarily the Chilean peso and yen |
| And maybe sticking with the US on the pension risk transfer market, it seems like maybe the market for full plan terminations has been heating up a little bit |
| So, nothing out of the ordinary given the environment |
| It seems like the economy in Japan at least is reengaging or reopening |
| The Group Life mortality ratio was 83.6% favorable to the prior year quarter of 85.7% and below the bottom end of our annual target range of 85% to 90% |
| I take issue with your deceptively comments |
| Underscoring that quality, the credit metrics associated with our real estate portfolio remain largely unchanged sequentially and we did not incur material credit losses during the third quarter |
Please consider a small donation if you think this website provides you with relevant information